Asia Vets Holdings (5RE) Fair Value & Analysis
Healthcare · SG · Market cap 11.0M SGD
Fair value as of: Jul 4, 2026
From 9 valuation models · updated today
Share price −21.1% over the past month.
Price vs Fair Value (12 months)
12‑month range 0.0210 SGD – 0.1050 SGD · the 0.0750 SGD price screens above the 0.0638 SGD fair value. As of Jul 4, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Asia Vets Holdings (5RE) currently trades at 0.0750 SGD, while our model-based Fair Value estimate is 0.0638 SGD — implying the stock looks roughly 15.0% overvalued today. We read business quality at 61/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
Trailing-twelve-month revenue stands at 2.3M SGD. Revenue grew 0.6% year over year. It earns a return on equity of -51.2%. Fundamentals as of Jul 4, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 4, 2026. TTM = trailing twelve months.
About the company
Asia Vets Holdings Ltd., through its subsidiary, AVH Animal Ark Pte. Ltd., provides veterinary care and clinical services to small animals in Singapore. The company operates two veterinary clinics, which provides general veterinary services including medical, surgical, and dental care for small animals, such as dogs, cats, rabbits, hamsters, guinea pigs, and chinchillas. It also provides vaccination, health check, dentistry, acupuncture, and traditional Chinese medicines; and natural killer cell and stem cell therapies, in-house blood tests, such as biochemistry and hematology, interventional radiology and endoscopy, surgery and invasive procedures, and pet diet prescription services, as well as diagnostic imaging, which includes ultrasonography, digital radiography, laparoscopy, and endoscopy. Asia Vets Holdings Ltd. was formerly known as Smartflex Holdings Ltd. and changed its name to Asia Vets Holdings Ltd. in July 2018. The company was incorporated in 2010 and is headquartered …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Asia Vets Holdings reported revenue of 2.3M SGD in FY2025 versus 3.1M SGD in FY2021, a compound −6.7%/yr. Reported net income was −6.5M SGD in FY2025.
Is 5RE fairly valued? → Check now
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 4, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$96.00 | R$25.67 | -73% |
| Fresenius SE FSNUY | $11.27 | $8.25 | -27% |
| Q0F Q0F | 2.76 SGD | 1.28 SGD | -54% |
| 5225 5225 | 8.70 MYR | 2.61 MYR | -70% |
| IHHHF IHHHF | $1.71 | $1.26 | -26% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.83 | R$46.94 | +39% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Asia Vets Holdings (5RE) undervalued?
What is the fair value of 5RE?
What is the quality score of 5RE?
What is the revenue of Asia Vets Holdings (5RE)?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.